MENU
BGLC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioNexus Gene Lab (BGLC) Ownership - Who owns BioNexus Gene Lab?
Profile
Industry
N/A
Address
No. 8 Jalan Kerinchi
Phone
+60 122126512
Employees
15
Web
https://www.bionexusgenelab.com
Details
Group
Domestic Stock Funds
Category
Process Industries
Capitalization
11.21M
P/E Ratio
N/A
Total Cash
6.15M
Projected Growth
N/A
Total Debt
138.76K
Revenue
10.34M
Risk (Beta)
2.43
Dividend Yield
N/A
Total Cash/Share
0.35
Total Debt/Equity
N/A
Revenue/Share
0.58 USD as % of share price
Fundamentals
BGLC
Capitalization
11.2M
P/E Ratio
N/A
Risk (Beta)
2.43
Dividend Yield
N/A
Total Cash
6.15M
Total Cash/Share
0.35
Total Debt
139K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.58%
Revenue
10.3M
ROE
N/A
Book Value
9.69M
P/B Ratio
1.16
Cash Flow
N/A
Earnings
-0.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.3M
Current Ratio
5.03
Current Revenue Per Employee
65479.13
Dividends Per Share - Security
N/A
EBITDA
-2.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
13.88
Revenue To Assets
-32.12
Shares Held By Institutions
92.7K
Shares Outstanding - Current
17.8M
Total Liabilities
1.78M
Total Volume MTD
N/A
Value
-1
Gain YTD
-39.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry ChemicalsSpecialty
Profile
Fundamentals
Details
Industry
N/A
Address
No. 8 Jalan Kerinchi
Phone
+60 122126512
Employees
15
Web
https://www.bionexusgenelab.com